It is becoming evident with time that the transcription factor Nrf2 can suppress tumorigenesis as well as protect tumors against oxidative stress, and different forms of cancer may exhibit dysregulation of the signaling pathway at different levels, contexts, and downstream mechanisms. This evidence concerns the gene NFE2L2 and cancer.